Projects per year
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
Sandrine Aspeslagh
- UZBrussel
- Vrije Universiteit Brussel
- Internal medicine - UZB Physician
- https://lmmo.research.vub.be/en/home
- Clinical sciences
- Medical Oncology - UZB Physician
Person: Researcher, Physician, Professor
-
Gil Awada
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences - Undefined
- Medical Oncology - UZB Physician
- https://lmmo.research.vub.be/en/home
Person: Researcher, Physician
-
Lore Decoster
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences
- Medical Oncology - UZB Physician
- https://lmmo.research.vub.be/en/home
Person: Researcher, Physician
-
Amy de Haar-Holleman
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences - Undefined
- https://lmmo.research.vub.be/en/home
- Medical Oncology - UZB Physician
Person: Researcher, Physician
-
Iris Dirven
- UZBrussel
- Vrije Universiteit Brussel
- https://lmmo.research.vub.be/en/home
- Clinical sciences - Doctoral scholarschip
- Medical Oncology - UZB Physician
- Faculty of Medicine and Pharmacy
Person: Researcher, Physician, PhD, Advanced Master's Programme
Projects
- 4 Finished
-
AIIFUND73: Inequities at the end-of-life-in cancer and Dementia: A Mixed-Methods study
Van den Block, L., Gilissen, J. & Decoster, L.
1/06/21 → 30/06/23
Project: Fundamental
-
IWTOO24: Baekeland mandate: preclinical development of an mRNA cancer vaccine for intravenous administration
1/02/18 → 31/01/22
Project: Applied
-
IWTOO25: Baekeland mandate: In situ mRNA vaccination: bringing the fight to the tumor
Breckpot, K., Thielemans, K. & Locy, H.
1/01/18 → 30/11/22
Project: Applied
Research output
-
1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases
Dirven, I., Vander Mijnsbrugge, A-S., Tijtgat, J., Vounckx, M. & Neyns, B., Oct 2023.Research output: Unpublished contribution to conference › Poster
-
1136P Regorafenib combined with BRAF-/MEK-inhibitors for the treatment of refractory melanoma brain metastases
Dirven, I., Vander Mijnsbrugge, A-S., Tijtgat, J., Vounckx, M. & Neyns, B., Oct 2023, In: Annals of Oncology. 34, 2, p. S681-S681 1 p.Research output: Contribution to journal › Conference paper
Open Access -
1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Vanlaer, N., Dirven, I., Vounckx, M., Tijtgat, J., Verhaert, M., Aspeslagh, S., Decoster, L., Rogiers, A. & Neyns, B., Oct 2023, In: Annals of Oncology. 34, 1 p., 1860P.Research output: Contribution to journal › Meeting abstract (Journal)
Open Access -
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 others, , 2023.Research output: Unpublished contribution to conference › Unpublished abstract
-
Analysis of cell-free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: a case series
Dirven, I., Hautman, R. M. A., Awada, G., Tijtgat, J., Vounckx, M., Vanbinst, A. & Neyns, B., 21 Apr 2023, (Unpublished).Research output: Unpublished contribution to conference › Other
Activities
-
Kom Op Tegen Kanker projectaanvraag
Marthe Verhaert (Participant)
14 Feb 2023Activity: Other › Written proposal
-
2023 SITC-Merck Cancer Immunotherapy Clinical Fellowship
Marthe Verhaert (Participant)
14 Apr 2023Activity: Other › Written proposal
-
Donateursontmoeting KOTK
Iris Dirven (Speaker)
13 Oct 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
Donateursontmoeting Kom Op Tegen Kanker
Manon Vounckx (Speaker) & Iris Dirven (Speaker)
13 Oct 2023Activity: Talk or presentation › Talk at a public lecture/debate
-
Identification of novel biomarkers for long-term response on immunotherapy in non-small cell lung cancer patients
Kirsten De Ridder (Speaker), Philippe Giron (Contributor), Sohrab Nazari (Contributor), Karolien Leona K Vekens (Contributor), Cleo Goyvaerts (Contributor) & Lore Decoster (Contributor)
10 Nov 2023 → 12 Nov 2023Activity: Talk or presentation › Talk or presentation at a conference
Datasets
-
Additional file 6: of Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
Van Dooren, S. (Creator), Teugels, E. (Creator), Bonduelle, M. (Creator), Shahi, R. B. (Creator), De Brakeleer, S. (Creator), Vanhoeij, M. (Creator), Joris, S. (Creator), Fontaine, C. (Creator), Pauwels, I. (Creator), Caljon, B. (Creator) & De Grève, J. (Creator), Springer, 2019
DOI: 10.6084/m9.figshare.7956710, http://10.1186/s12885-019-5494-7
Dataset